Throwing Precision Darts: The Company Leading Next Evolution of Cancer Radiation [Globe and Mail, The (Toronto, Canada)]
Alpha Tau Medical Ltd. - Ordinary Shares (DRTS)
Company Research
Source: Globe and Mail, The
has remained the same: deliver enough energy to destroy tumors while sparing healthy tissue. What has changed, gradually, then suddenly, is the level of precision clinicians can bring to that task. A new generation of technologies is pushing radiation beyond its historical limits, opening therapeutic possibilities for patients who previously had few or no options. Alpha Tau Medical Ltd. (Nasdaq: DRTS) sits at the center of that shift. The company is developing Alpha DaRT® (Diffusing Alpha-emitters Radiation Therapy), a localized treatment designed to harness the destructive power of alpha particles inside solid tumors. Alpha particles have long been known for their ability to cause irreparable double-strand DNA breaks, but their extremely short range historically made them impractical for treating solid cancers. Alpha Tau's approach addresses that limitation by allowing alpha-emitting atoms to diffuse throughout tumor tissue after intratumoral placement, extending therapeutic reach
Show less
Read more
Impact Snapshot
Event Time:
DRTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DRTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DRTS alerts
High impacting Alpha Tau Medical Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
DRTS
News
- Wall Street Breakfast Podcast: Selloff To Surge In Defense [Seeking Alpha]Seeking Alpha
- Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study [Yahoo! Finance]Yahoo! Finance
- Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® StudyGlobeNewswire
- Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC) [Yahoo! Finance]Yahoo! Finance
- Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)GlobeNewswire
DRTS
Earnings
- 11/20/25 - Beat
DRTS
Sec Filings
- 1/14/26 - Form 144
- 1/12/26 - Form 144
- 1/9/26 - Form 144
- DRTS's page on the SEC website